NCC MEDICAL GROUP is a globally recognized developer and manufacturer of advanced neurodiagnostic and neuro-monitoring technologies. As a National Specialized, Refined, Differential, and Innovational (SRDI) “Little Giant” Enterprise, NCC represents one of the most innovative technology leaders in the neurophysiology industry. The SRDI designation is awarded by government authorities to companies that demonstrate strong research capabilities, patented technologies, and outstanding contributions to strategic high-tech industries.
Founded in 1997, NCC has more than two decades of experience in developing sophisticated solutions for neurological diagnostics and intraoperative monitoring. The company operates a dual-hub structure designed to ensure both technological innovation and international compliance. Its primary research and manufacturing center is located in Shanghai, China, where multidisciplinary engineering teams focus on neurophysiology hardware design, signal processing algorithms, and precision manufacturing. Meanwhile, NCC’s global quality and regulatory hub in Singapore oversees international compliance, certification processes, and global supply chain coordination.
NCC specializes in a comprehensive portfolio of neurophysiology solutions, including Intraoperative Neuromonitoring (IONM) systems, EEG and PSG diagnostic platforms, EMG diagnostic equipment, and high-precision medical consumables such as electrodes and sensors. These technologies play a vital role in neurosurgery, orthopedic surgery, sleep medicine, rehabilitation, and neurological research.
One of NCC’s key strengths lies in its vertically integrated development approach. The company combines hardware engineering, embedded software design, signal processing algorithms, and clinical workflow optimization into a unified development framework. This approach ensures that NCC systems deliver both technical excellence and practical usability in real clinical environments.
NCC’s clinical technologies are currently deployed in more than 50 countries worldwide, supporting neurological diagnostics and monitoring in hospitals, surgical centers, and research laboratories. Within China alone, over 5,000 hospitals rely on NCC equipment for daily neurodiagnostic procedures. Internationally, NCC solutions are widely used across Southeast Asia, Australia, Europe, North America, South America, and Africa.
To support healthcare professionals worldwide, NCC operates 31 training and technical support centers across China. These centers provide structured training programs for neurologists, neurophysiology technicians, and biomedical engineers. Through hands-on workshops, simulation training, and continuing education courses, NCC ensures that medical professionals can fully utilize advanced neurodiagnostic technologies.
In addition to its domestic training network, NCC is actively expanding its global distributor ecosystem, building partnerships with regional distributors and clinical technology providers. This strategy enables faster technical support, localized service capabilities, and improved accessibility to NCC solutions in international markets.
The company also promotes interdisciplinary collaboration through its NeuGuard Service Platform and the NCC Innovation Academy. These initiatives connect clinicians, researchers, and engineers to accelerate the development of safer surgical monitoring techniques, more precise neurological diagnostics, and next-generation neurotechnology.
Guided by its mission of “Safeguarding Life and Health,” NCC continues to push the boundaries of neurophysiology innovation. By combining advanced technology, clinical expertise, and global collaboration, NCC MEDICAL GROUP is committed to improving patient outcomes and advancing neurological healthcare worldwide.
Copyright © NCC Medical Co., Ltd. - Privacy policy